165 related articles for article (PubMed ID: 12975593)
1. Prevention of nitrate tolerance by long-term treatment with statins.
Fontaine D; Otto A; Fontaine J; Berkenboom G
Cardiovasc Drugs Ther; 2003 Mar; 17(2):123-8. PubMed ID: 12975593
[TBL] [Abstract][Full Text] [Related]
2. Rosuvastatin treatment protects against nitrate-induced oxidative stress.
Otto A; Fontaine D; Fontaine J; Berkenboom G
J Cardiovasc Pharmacol; 2005 Aug; 46(2):177-84. PubMed ID: 16044029
[TBL] [Abstract][Full Text] [Related]
3. Rosuvastatin treatment protects against nitrate-induced oxidative stress in eNOS knockout mice: implication of the NAD(P)H oxidase pathway.
Otto A; Fontaine J; Tschirhart E; Fontaine D; Berkenboom G
Br J Pharmacol; 2006 Jun; 148(4):544-52. PubMed ID: 16633368
[TBL] [Abstract][Full Text] [Related]
4. Ramipril treatment protects against nitrate-induced oxidative stress in eNOS-/- mice: An implication of the NADPH oxidase pathway.
Otto A; Fontaine J; Berkenboom G
J Cardiovasc Pharmacol; 2006 Jul; 48(1):842-9. PubMed ID: 16891913
[TBL] [Abstract][Full Text] [Related]
5. Absence of nitrate tolerance after long-term treatment with ramipril: an endothelium-dependent mechanism.
Berkenboom G; Fontaine D; Unger P; Baldassarre S; Preumont N; Fontaine J
J Cardiovasc Pharmacol; 1999 Oct; 34(4):547-53. PubMed ID: 10511130
[TBL] [Abstract][Full Text] [Related]
6. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance.
Münzel T; Sayegh H; Freeman BA; Tarpey MM; Harrison DG
J Clin Invest; 1995 Jan; 95(1):187-94. PubMed ID: 7814613
[TBL] [Abstract][Full Text] [Related]
7. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation.
Wagner AH; Köhler T; Rückschloss U; Just I; Hecker M
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):61-9. PubMed ID: 10634801
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a causal role of the renin-angiotensin system in nitrate tolerance.
Kurz S; Hink U; Nickenig G; Borthayre AB; Harrison DG; Münzel T
Circulation; 1999 Jun; 99(24):3181-7. PubMed ID: 10377083
[TBL] [Abstract][Full Text] [Related]
9. Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability.
Münzel T; Li H; Mollnau H; Hink U; Matheis E; Hartmann M; Oelze M; Skatchkov M; Warnholtz A; Duncker L; Meinertz T; Förstermann U
Circ Res; 2000 Jan; 86(1):E7-E12. PubMed ID: 10625313
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of statins on endogenous H2S formation in perivascular adipose tissue.
Wójcicka G; Jamroz-Wiśniewska A; Atanasova P; Chaldakov GN; Chylińska-Kula B; Bełtowski J
Pharmacol Res; 2011 Jan; 63(1):68-76. PubMed ID: 20969959
[TBL] [Abstract][Full Text] [Related]
11. The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin.
Rakotoniaina Z; Guerard P; Lirussi F; Goirand F; Rochette L; Dumas M; Bardou M
Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):195-206. PubMed ID: 17102939
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin ameliorates arsenic-induced hypertension and enhancement of vascular redox signaling in rats.
Sarath TS; Waghe P; Gupta P; Choudhury S; Kannan K; Pillai AH; Harikumar SK; Mishra SK; Sarkar SN
Toxicol Appl Pharmacol; 2014 Nov; 280(3):443-54. PubMed ID: 25218292
[TBL] [Abstract][Full Text] [Related]
13. Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aorta.
Mülsch A; Oelze M; Klöss S; Mollnau H; Töpfer A; Smolenski A; Walter U; Stasch JP; Warnholtz A; Hink U; Meinertz T; Münzel T
Circulation; 2001 May; 103(17):2188-94. PubMed ID: 11331261
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin prevents end-organ injury in salt-sensitive hypertension: role of eNOS and oxidant stress.
Zhou MS; Jaimes EA; Raij L
Hypertension; 2004 Aug; 44(2):186-90. PubMed ID: 15238570
[TBL] [Abstract][Full Text] [Related]
16. Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice.
Vecchione C; Brandes RP
Circ Res; 2002 Jul; 91(2):173-9. PubMed ID: 12142351
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
[TBL] [Abstract][Full Text] [Related]
18. Long-term atorvastatin improves age-related endothelial dysfunction by ameliorating oxidative stress and normalizing eNOS/iNOS imbalance in rat aorta.
Gong X; Ma Y; Ruan Y; Fu G; Wu S
Exp Gerontol; 2014 Apr; 52():9-17. PubMed ID: 24463049
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of ITF 296-induced vasorelaxation compared to nitroglycerin and isosorbide dinitrate: relationship between relaxation of rabbit aorta and tissue cGMP.
Donà G; Giuliani P; Cremonesi P; Passaro A; Stella P; Tursi F; Mizrahi J
J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S59-66. PubMed ID: 8839228
[TBL] [Abstract][Full Text] [Related]
20. Platelet nitric oxide and superoxide release during the development of nitrate tolerance: effect of supplemental ascorbate.
McVeigh GE; Hamilton P; Wilson M; Hanratty CG; Leahey WJ; Devine AB; Morgan DG; Dixon LJ; McGrath LT
Circulation; 2002 Jul; 106(2):208-13. PubMed ID: 12105160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
